-
Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer
Study
EGAS00001007501
-
RNASeq Neoantigen Immunogenicity Landscape
Study
EGAS00001007509
-
Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring
Study
EGAS00001007545
-
Immune and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 trials
Study
EGAS00001007563
-
Idiosyncratic and generic single nuclei and spatial transcriptional patterns in papillary and anaplastic thyroid cancers
Study
EGAS00001007574
-
DERMATLAS__Leiomyoma_WES
Study
EGAS00001007629
-
DERMATLAS__Leiomyoma_RNAseq
Study
EGAS00001007630
-
DERMATLAS__Leiomyosarcoma_RNAseq
Study
EGAS00001007631
-
Buccal Sample Methylation for Breast Cancer Detection
Study
EGAS00001007658
-
Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with Constitutional Mismatch Repair Deficiency
Study
EGAS00001007660
-
DNA-methylation variability in normal mucosa of patients with adenomatous polyps: a marker of field cancerization
Study
EGAS00001007666
-
Evaluation of EBUS-TBNA Aspirates from Advanced NSCLC for Comprehensive Sequencing Platforms Including Whole Genome Sequencing
Study
EGAS00001007708
-
Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression
Study
EGAS00001007766
-
To_profile_the_landscape_of_sebaceous_tumours___RNA
Study
EGAS00001007803
-
MethylationEPIC BeadChip samples of pre- and post-5ZA-treated head and neck cancer patients refractory to anto-PD-1 therapy
Study
EGAS00001007998
-
Phosphoproteomics adds value to treatment recommendations in molecular tumor boards
Study
EGAS00001007891
-
The University of Hong Kong Intestinal Metaplasia Organoids Study
Study
EGAS00001007899
-
Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer
Study
EGAS00001007911
-
Multi-Layered Molecular Profiling Informs the Diagnosis and Targeted Therapy of Desmoplastic Small Round Cell Tumor
Study
EGAS00001007934
-
Integrated genomic analysis for HCC
Study
EGAS00001007957
-
A standardised framework for robust fragmentomic feature extraction from cell-free DNA sequencing data
Study
EGAS00001008051
-
This study generated Oxford Nanopore long read sequencing data of cancer cell line mixtures for validating long-read variant calls in cancer genomics
Study
EGAS00001008107
-
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma
Study
EGAS00001008059
-
Detection of cancers three years prior to diagnosis using plasma cell-free DNA
Study
EGAS00001008068
-
Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma
Study
EGAS00001008140
-
Single cell TCRseq data fromTIL and non-TIL expanded TRACERx samples in the manuscript Bulk TCRseq from TRACERx samples from 'Subclonal immune evasion in non-small cell lung cancer'
Study
EGAS00001008161
-
Transcriptomic predictors of survival for palbociclib + endocrine therapy vs. capecitabine in aromatase inhibitor-resistant breast cancer from GEICAM/2013-02 PEARL
Study
EGAS00001008177
-
Cold Ischemia Study
Study
EGAS00001008233
-
Colorectal Microenvironment Spatial Mapping
Study
EGAS00001008254
-
Whole genome sequencing of tumor samples from advanced pre-treated NSCLC patients recruited in a phase I/II single-arm trial utilising CVA21, an oncolytic coxsackie virus, in combination with pembrolizumab.
Study
EGAS00001008258
-
Single_cell_RNA_sequencing_of_rhabdomyosarcoma_tumour_tissue
Study
EGAS00001008271
-
Cell-free DNA sequencing data of healthy control, atrophic gastritis, and gastric cancer patients’ blood
Study
EGAS00001007308
-
Whole_Genome_sequencing_of_rhabdomyosarcoma_tumour_tissue
Study
EGAS00001008274
-
Single_cell_ATAC_sequencing_of_rhabdomyosarcoma_tumour_tissue
Study
EGAS00001008276
-
Single_cell_ATAC_sequencing_of_rhabdomyosarcoma_tumour_tissue
Study
EGAS00001008279
-
Organoid_Derivation_Project___GRCh38___TGS
Study
EGAS00001007349
-
Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling
Study
EGAS00001008353
-
Sequencing of patient tissue and patient derived organoids in colon cancer
Study
EGAS00001008067
-
MorphoITH: A Framework for Deconvolving Intra-Tumor Heterogeneity Using Tissue Morphology
Study
EGAS50000001064
-
RNA sequencing data of 142 samples from 142 patients with HER2+ breast cancer treated with letrozole or tamoxifen (SOLTI PAMELA trial)
Study
EGAS00001006410
-
NOUS-209 off-the-shelf immunotherapy has the potential to hit primary and metachronous colorectal and urothelial cancer in Lynch syndrome
Study
EGAS50000001336
-
ctDNA multigenic panel for non-small cell lung cancer
Study
EGAS50000000643
-
IMMUcan Upstream SCCHN3 cohort
Study
EGAS50000001505
-
IMMUcan SCCHN1 cohort
Study
EGAS50000001533
-
TCR β-chain repertoire characterization of regulatory and conventional T cells in peripheral blood from breast cancer patients and healthy individuals.
Study
EGAS00001002699
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__clear_cell_renal_cell_carcinoma
Study
EGAS00001002608
-
Preferential infiltration of distinct Vγ9δ2 T cells into Glioblastoma multiforme
Study
EGAS00001002790
-
Sensitive and Frequent Identification of High Avidity Neo-epitope Specific CD8 + T-cells in Immunotherapy-naïve Ovarian Cancer
Study
EGAS00001002803
-
Pan Prostate Cancer Group data
Study
EGAS00001002876
-
“Castration-persistence” is a distinct state of tolerance to androgen receptor targeting therapies in prostate cancer
Study
EGAS00001003172
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia
Study
EGAS00001004407
-
FOXM1 is a biomarker of resistance to PI3Kα inhibition in ER+ breast cancer that is detectable using metabolic imaging (RNA-seq data)
Study
EGAS00001004452
-
Clinical relevance of somatic copy-number alterations in plasma circulating tumor DNA from advanced EGFR-mutated NSCLC patients treated with osimertinib
Study
EGAS00001004539
-
TCR β-chain repertoire characterization of regulatory and conventional T cells in breast tumors from breast cancer patients.
Study
EGAS00001004671
-
Assessment of cannabidiol and Δ9-tetrahydrocannabiol in mouse models of medulloblastoma
Study
EGAS00001004963
-
Single-cell profiling of neoantigen-specific T cells in lung cancers treated with neoadjuvant PD-1 blockade
Study
EGAS00001005343
-
RNA-sequencing of tumors from 45 patients with recurrent or metastatic gastric cancer treated with immune checkpoint inhibitors
Study
EGAS00001005588
-
Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers
Study
EGAS00001005676
-
Mult-omics Palbociclib Resistance Study in HR+/HER2– Metastatic Breast Cancer
Study
EGAS00001005736
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001005738
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001005747
-
Accumulation of copy number alterations and clinical progression across advanced prostate cancer
Study
EGAS00001006251
-
early-stage ESCC sequencing study
Study
EGAS00001006126
-
Genome-wide cell-free DNA termini in patients with cancer
Study
EGAS00001006142
-
Intratumoral Heterogeneity and Clonal Evolution Induced by HPV Integration.
Study
EGAS00001006652
-
RNA-seq of DF149 cells – a patient-derived xenograft model of ascites-derived, homologous recombination repair-proficient, high-grade serous ovarian carcinoma – cultured in vitro and isolated after 8 hours treatment with DMSO control (3 x biological replicates) and 2.5 µM CBL0137 (3 x biological replicates)
Study
EGAS00001006662
-
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification (H021)
Study
EGAS00001006706
-
Non-muscle Invasive Bladder Cancer Molecular Subtypes Predict Differential Response to Intravesical Bacillus Calmette-Guérin
Study
EGAS00001006879
-
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions(H021/INF)
Study
EGAS00001006939
-
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
Study
EGAS00001007077
-
Implementation of pediatric precision oncology into clinical practice: The individualized Therapies for Children with cancer program “iTHER”
Study
EGAS00001007099
-
Single-cell decoding of drug induced transcriptomic reprogramming in triple negative breast cancers
Study
EGAS00001007242
-
Clinical outcomes and immune correlates of response to nivolumab plus chemoradiotherapy in women with locally-advanced cervical cancer – NiCOL study
Study
EGAS00001007297
-
Pediatric Patient-Derived-Xenograft development in MAPPYACTS – international pediatric cancer precision medicine trial in relapsed and refractory tumors
Study
EGAS00001007327
-
Genome-wide cell-free DNA biological patterns in patients with cancer
Study
EGAS00001007400
-
SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors
Study
EGAS00001007590
-
Metabolic profiling of patient-derived organoids reveals nucleotide synthesis as a metabolic vulnerability in malignant rhabdoid tumors
Study
EGAS00001007877
-
Genome-wide association study identifies common variants associated with breast cancer in South African Black women
Study
EGAS00001008032
-
Cancer of Low survival and UnMet Need – Pathologist Initiated
Study
EGAS00001008112
-
Sequencing data from MethylScan assay on plasma
Study
EGAS00001008127
-
Single-cell and spatial transcriptomic profiling of hormone-naïve localised prostate cancer
Study
EGAS00001008332